Methohexital sodium
-
Methohexital sodium
structure -
-
CAS No:
309-36-4
-
Formula:
C14H18N2O3.Na
-
Chemical Name:
Methohexital sodium
-
Synonyms:
2,4,6(1H,3H,5H)-Pyrimidinetrione,1-methyl-5-(1-methyl-2-pentyn-1-yl)-5-(2-propen-1-yl)-,sodium salt (1:1);Barbituric acid,5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-,sodium salt;2,4,6(1H,3H,5H)-Pyrimidinetrione,1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-,sodium salt;Barbituric acid,5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-,sodium deriv.;Sodium methohexital;Methohexital sodium;Sodium methohexitone;Brevital sodium;Brietal sodium;Enallynymal sodium;Methohexitone sodium;Brevimytal;Brevimytal sodium;22151-68-4;32671-83-3;33975-80-3;60634-69-7
- Categories:
-
CAS No:
Description
ChEBI: The sodium salt of methohexital.
Sodium methohexital is a white powder. (NTP, 1992)
Sodium methohexital is a white powder. (NTP, 1992)|Methohexital sodium is the sodium salt of methohexital. It has a role as an intravenous anaesthetic. It contains a methohexital(1-).|Brevital is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.|Methohexital Sodium is the sodium salt of methohexital, a rapid, short-acting barbituric acid derivative, with anesthetic activity. Methohexital binds to the chloride ionophore site of the gamma-aminobutyric acid (GABA)-A/chloride ionophore receptor complex, thereby enhancing the inhibitory actions of GABA-A in the brain. This leads to synaptic inhibition, decreased neuronal excitability and induction of anesthesia. In addition, this agent decreases glutamate (Glu) responses.|An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia.
Characteristics
57.69000
1.35910
Sodium methohexital is a white powder. (NTP, 1992)
140 to 147 °F (NTP, 1992)
382.1ºC at 760mmHg
184.9ºC
greater than or equal to 100 mg/mL at 66° F (NTP, 1992)
Water soluble.
Amides and Imides
Solutions of this material are incompatible with silicone and acid. (NTP, 1992).
Safety Information
III
6.1(b)
UN 3249
Flash point data are not available for this chemical, but it is probably combustible. (NTP, 1992)
Fires involving this compound should be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
Excerpt from ERG Guide 151 [Substances - Toxic (Non-combustible)]: As an immediate precautionary measure, isolate spill or leak area in all directions for at least 50 meters (150 feet) for liquids and at least 25 meters (75 feet) for solids. SPILL: Increase, in the downwind direction, as necessary, the isolation distance shown above. FIRE: If tank, rail car or tank truck is involved in a fire, ISOLATE for 800 meters (1/2 mile) in all directions; also, consider initial evacuation for 800 meters (1/2 mile) in all directions. (ERG, 2016)
SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a strong soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned. STORAGE PRECAUTIONS: This compound is a Schedule IV DEA Controlled Substance and is to be stored according to State and Federal Regulations. Refer to Code of Federal Regulations Title 21 Part 1300 to End. (NTP, 1992)
RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with a combination filter cartridge, i.e. organic vapor/acid gas/HEPA (specific for organic vapors, HCl, acid gas, SO2 and a high efficiency particulate filter). (NTP, 1992)
Drug Information
Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)
SYMPTOMS: Allergic reactions to this chemical are manifested by redness and itching of the skin, shortness of breath, anxiety, abdominal pain, restlessness and peripheral vascular collapse. Other toxic reactions include nausea, vomiting, salivation, delirium, circulatory depression, thrombophlebitis, respiratory depression(including apnea), laryngospasm, bronchospasm and hiccups. ACUTE/CHRONIC HAZARDS: This compound may cause allergic reactions in susceptible individuals. This is commonly manifested by skin rash and itching. (NTP, 1992)
EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop. SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment. INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing. INGESTION: If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Generally, the induction of vomiting is NOT recommended outside of a physician's care due to the risk of aspirating the chemical into the victim's lungs. However, if the victim is conscious and not convulsing and if medical help is not readily available, consider the risk of inducing vomiting because of the high toxicity of the chemical ingested. Ipecac syrup or salt water may be used in such an emergency. IMMEDIATELY transport the victim to a hospital. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)
Brevimytal Natrium
Methohexital|Brevital|2264|Schedule IV - Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.|No
Methohexital sodium Use and Manufacturing
Anesthetic (intravenous).
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:284.29
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:284.11368669
Monoisotopic Mass:284.11368669
Topological Polar Surface Area:72.8
Heavy Atom Count:20
Complexity:515
Undefined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of Methohexital sodium
-
CN
4 YRS
Business licensedTrader Supplier of Fluorine containing fine chemicals Pharmaceutical
Learn More Other Chemicals
-
Desacetyl Cephapirin SodiuM Salt
104557-24-6
-
D-Fructose, 1,6-bis(dihydrogen phosphate), sodium salt (1:4)
23784-19-2
-
Glucose 1-phosphate sodium salt
17364-14-6
-
Poly(oxy-1,2-ethanediyl), α-(carboxymethyl)-ω-(decyloxy)-, sodium salt (1:1) Formula
38815-93-9
-
DIAMMONIUM SODIUM HEXANITRORHODATE(III)& Formula
14640-47-2
-
DECANOIC ACID-CARBOXY-14C SODIUM Formula
94033-36-0
-
1H-Tetrazole-1-acetic acid, 2,5-dihydro-5-thioxo-, sodium salt (1:1) Structure
113221-74-2
-
Phosphonic acid, (dichloromethylene)bis-, sodium salt Structure
29329-69-9
-
What is Benzoic acid, 2,3-dichloro-, sodium salt (1:1)
118537-84-1
-
What is Sodium arsenate heptahydrate
10048-95-0